ResourcesBioProcess Insider Interview with Steve Burton

Having spent 30 years in the biopharmaceutical industry, Burton has witnessed monumental shifts in biomanufacturing. However, he reflected that “many of the original challenges remain, but in a new context.” Cell-line development and high titers occupied researchers’ minds in the early days. “The extraction and purification of those proteins into a good manufacturing practice (GMP)-quality product fit for administration to humans was almost a secondary thought.”